In 2006, the U.S. Food and Drug Administration (FDA) approved a 9-valent vaccine that protects against nononcogenic HPV types 6 and 11 and oncogenic HPV types 16, 18, 31, 33, 45, 52, and 58 (Gardasil 9). Because it offers broader coverage of HPV types than other vaccines, the 9-valent vaccine is the only HPV vaccine available in the United States (see the Centers for Disease Control and Prevention [CDC] Supplemental information and guidance for vaccination providers regarding use of 9-valent HPV for more information). The HPV vaccine is approved by the FDA for preventive but not therapeutic use.
6 Obligations to examine and to notify6.1 Licensee is obliged to examine the Software for any evident faults. An evident fault means a fault obvious to the average Licensee. Unless Licensor is notified of such faults within 14 days of downloading the Software, the warranty will expire.
Download Guida Cei 31 35 Pdf
2ff7e9595c
Comments